Substance Dependence Satisfaction With Care and Quality Of Life

Alcoholism Clinical Trial

— SUBUSQOL  

Official title:

Satisfaction With Care and Quality of Life in Subjects With Substance Dependence

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02894476
• Other study ID #: SUBUSQOL
• Status: Recruiting
• Phase: N/A
• First received: August 26, 2016
• Last updated: September 5, 2016
• Start date: April 2014
• Est. completion date: March 2018

Study information

• Verified date: September 2016
• Source: Central Hospital, Nancy, France
• Contact: Stéphanie , BOURION-BEDES, MD-PhD
• Email: steph_bedes[@]yahoo.fr
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertés
• Study type: Observational

Clinical Trial Summary

The SUBUSQOL cohort aimed to improve knowledge of the quality of ambulatory care, in particular the prognostic role of the early satisfaction with care on the change from baseline quality of self-reported health status in outpatients with alcohol or opioid dependence. It is a multicenter prospective cohort. Satisfaction was assessed using a multidimensional self-administered and validated questionnaire during the early care process. In addition to measuring satisfaction and obtaining sociodemographic and clinical data, this study collected data on the self-reported health status at inclusion and 3, 6 and 12 months after inclusion.

Description:

Early satisfaction with care was measured using the quality of care satisfaction questionnaire in outpatient consultation (EQS-C). Data collected during the study included patient sociodemographic, clinical and health status characteristics, as well as physician characteristics. Self-perceived quality of life was assessed using the generic SF-12 and a specific questionnaire in illness disease, the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 600
• Est. completion date: March 2018
• Est. primary completion date: March 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Outpatients who met the Diagnostic and Statistical Manual, fourth edition (DSM-IV) criteria for alcohol dependence, opioid dependence, or both.

• Patients recruited from the French specialized addiction treatment centers where they began care.

• Patient agreement obtained

Exclusion Criteria:

• Age lower than 18 years

• Inability to complete self-questionnaires

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Alcoholism
• Early Satisfaction With Substance Dependence Care
• Opiate Dependence
• Opioid-Related Disorders
• Substance-Related Disorders

Locations

Country	Name	City	State
France	CHS (Hospital of Jury-les-Metz)	Jury-les-Metz
France	CSAPA (Healthcare Center of Accompaniment and Prevention in Addictology), University Hospital of Nancy	Nancy
France	ANPAA 15- CSAPA (Healthcare Center of Accompaniment and Prevention in Addictology)	Saint-Flour

Sponsors (3)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France	Healthcare Center of Accompaniment and Prevention in Addictology, Saint-Flour, France, Hospital of Jury-les-Metz, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life score	Self-perceived quality of life score using the Short-Form 12 questionnaire (SF-12)	Change from inclusion at 12 months	No
Primary	Quality of life score	Self-perceived quality of life score using the Quality of life enjoyment and satisfaction questionnaire short form (Q-LES-Q-SF)	Change from inclusion at 12 months	No
Secondary	Care satisfaction	Outpatient satisfaction score using the quality of care satisfaction questionnaire in outpatient consultation (EQS-C)	15 and 45 days after inclusion	No